Part the Cloud Enable the Molecule for Therapeutics (PTC-EMT) Funding Program
Alzheimer's Association
This program is designed to advance promising Alzheimer's and related disorders therapeutics through final stages of investigational new drug (IND) -enabling stages. This initiative supports high-potential therapeutic candidates, providing essential resources to expedite their translation into clinical application for Alzheimer's disease and related dementia.
Each grant is limited to up to $1M USD (direct and indirect costs) over two or three years.
Deadlines
| UM Internal Deadline | Sponsor Deadline | |
|---|---|---|
Letter of Intent |
| 06-Aug-2025 5:00 pm EST |
Application | 04-Sep-2025 4:30 pm CST | 24-Sep-2025 5:00 pm EST |
Important
The information in this directory is provided as a service to the University Community and anyone with legitimate business with the University. Use of this directory to prepare mass mailings is prohibited.